A novel bioengineering strategy utilizing peptide display technology on the AAV1 capsid has successfully generated next-generation viral vectors with ...

Researchers have identified the molecular mechanism behind vaccine-induced immune thrombotic thrombocytopenia, or VITT, a rare clotting disorder that emerged in a small number of people who received ...

Amsbio now offers a ready-to-use range of lentiviral particles designed to deliver target genes into virtually any mammalian cell type, both dividing and non-dividing, in vitro and in vivo. These ...

Advanced Gene Therapy Development Solutions: A Comprehensive Platform for Next-Generation Therapeutic Innovation: The landscape of gene therapy has evolved dramatically over the past decade, ...